LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [10/16/2026 13:20 PDT] LENSAR, Inc. (NASDAQ:LNSR), Down By 100% ($6.45) From $6.45 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/09/2026 06:50 PDT] LNSR Expected to Trade Down Short Term
• [09/22/2026 06:23 PDT] LNSR Expected to Trade Up After Bullish Patterns Develop
• [09/18/2026 06:18 PDT] LNSR Expected to Trade Up After Bullish Patterns Develop
• [09/17/2026 12:42 PDT] LENSAR, Inc. (NASDAQ:LNSR), Down By 100% ($8.3) From $8.3 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/17/2026 05:45 PDT] LNSR Expected to Trade Up After Bullish Patterns Develop
• [08/31/2026 05:40 PDT] LNSR Expected to Trade Down After Bearish Patterns Develop
• [08/24/2026 16:30 PDT] LNSR SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.